Contracts with patients in clinical practice
Volk M, Lieber SR, Kim SY, Ubel P, Schneider CE. Lancet 2011.

Variation in organ quality between liver transplant centers
Volk M, Reichert H, Lok AS, Hayward RH. American Journal of Transplantation 2011;11:958-64.

Patient involvement in health care is associated with higher rates of surveillance for hepatocellular carcinoma
Singal AS, Volk M, Rakoski MO, Marrero JA. Journal of Clinical Gastroenterology 2011. In Press.

Is MRCP equivalent to ERCP for diagnosing biliary obstruction in orthotopic liver transplant recipients? A meta-analysis
Jorgensen J, Waljee AK, Volk M, Al-Hawary M, Sonnenday CJ, Elmunzer BJ 2011;73(5):955-62.

Can quality of care for patients with cirrhosis be measured?
Volk M, Bassett JT 2011. In Press.

Burden of cirrhosis on older Americans and their families: Analysis of the Health and Retirement Study
Rakoski MO, McCammon RJ, Piette JD, Iwashyna TJ, Marrero JA, Lok AS, Langa K, Volk M. Hepatology 2011. In Press.

Organ quality and quality of life after liver transplantation
Volk M, Hagan M. Liver Transplantation 2011. In Press.

Hospital re-admissions among patients with decompensated cirrhosis
Volk M, Tocco R, Bazick J, Rakoski MO, Lok AS. American Journal of Gastroenterology 2011.

Decision making in liver transplant selection committees
Volk M, Biggins SW, Huang MA, Argo CK, Fontana RJ, Anspach R. Annals of Internal Medicine 2011. In Press.

Patient decision making about organ quality
Volk M, Tocco R, Pelletier SJ, Zikmund-Fisher BJ, Lok AS. Liver Transplantation 2011. In Press.

Unfair priority for HCC: A problem whose ideal solution remains unsolved
Volk M. American Journal of Transplantation 2010;10:1507-1508.

Use of Sorafenib in HCC patients before liver transplantation: A cost-benefit analysis while awaiting data on Sorafenib safety
Vitale A, Volk M, Pastorelli D, Lonardi S, Farinati F, Cillo U. Hepatology 2010;51(1):165-73.

A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus
Singal AG, Volk M, Jensen D, DiBisceglie A, Schoenfeld PS. Clinical Gastroenterology and Hepatology 2010;8(3):280-8.

The survival benefit of liver transplantation in hepatocellular carcinoma patients
Cillo U, Vitale A, Volk M, Frigo AC, Grigoletto F, Brolese A, Zanus G, Farinati F, D'Amico FD, Farinati F. Digestive and Liver Disease 2010;42:642.

Hepatotoxicity fears contribute to under-utilization of statin medications by primary care physicians
Rzouq FS, Volk M, Hatoum HH, Talluri SK, Mummadi RR, Sood SK. American Journal of the Medical Sciences 2010;340(2):89.

Estimation of the harm to the waiting list as a crucial factor in the selection of patients with hepatocellular carcinoma for liver transplantation
Vitale A, Volk M, Sensolo M, Burra P, Romano A, Angeli P, Cillo U, Gamato M, Zanus G, DAmico FD, Carraro A, Pauletto A, Bonsignore P, Scopelliti M, Pollaco M, Russo F. Transplantation Proceedings 2010;42(4):1194-6.

Chronic disease management for patients with cirrhosis
Volk M, Piette JD, Singal AS, Lok AS. Gastroenterology 2010;139:14-16.

Foreigners traveling to the U.S. for transplantation may adversely affect organ donation: A national survey
Volk M, Warren G, Anspach R, Couper M, Merion RM, Ubel PA. American Journal of Transplantation 2010;10:1468-1472.

Centers for Disease Control 'high-risk' donors and kidney utilization
Duan KI, Englesbe MJ, Volk M. American Journal of Transplantation 2010;10:416-420.

Attitudes of the American public toward organ donation after uncontrolled (sudden) cardiac death
Volk M, Warren G, Anspach R, Couper M, Merion RM, Ubel PA. American Journal of Transplantation 2010;10:675-680.

Public health impact of antiviral therapy for hepatitis C in the United States
Volk M, Tocco R, Saini S, Lok AS. Hepatology 2009;50(6):1750-1755.

Geographic variation in organ availability is responsible for disparities in liver transplantation between Hispanics and Caucasians
Volk M, Choi H, Warren G, Sonnenday CJ, Marrero JA, Heisler M. American Journal of Transplantation 2009;9:2113-2118.

Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation
Volk M, Lok AS, Pelletier SJ, Ubel PA, Hayward RA. Gastroenterology 2008;135(5):1568-74.

Beyond utilitarianism: A method for analyzing competing ethical principles in a decision analysis of liver transplantation.
Volk M, Lok AS, Ubel PA, Vijan S. Medical Decision Making 2008;28(5):763-772.

A gift of life: Ethical and practical problems with conditional and directed donation.
Volk M, Ubel PA. Transplantation 2008;85(11):1542-1544.

Liver transplantation for hepatocellular carcinoma: Who benefits and who is harmed?
Volk M, Marrero JA. Gastroenterology 2008;134:1612-1614.

A novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria.
Volk M, Vijan S, Marrero JA. American Journal of Transplantation 2008;8:839-846.

Early detection of liver cancer: Diagnosis and management.
Volk M, Marrero JA. Current Opinion in Gastroenterology 2008;10(1):60-66.

Modified Charlson Comorbidity Index for predicting survival after liver transplantation.
Volk M, Hernandez JC, Lok AS, Marrero JA. Liver Transplantation 2007;13:1515-1520.

Who decides? Living donor liver transplantation for advanced hepatocellular carcinoma.
Volk M, Marrero JA, Lok AS, Ubel PA. Transplantation 2006;82(9):1136-1139.